000 01635 a2200493 4500
005 20250514185701.0
264 0 _c20050104
008 200501s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/j.bmcl.2004.03.059
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNazaré, Marc
245 0 0 _aNovel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cJun 2004
300 _a2801-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBenzoates
_xchemical synthesis
650 0 4 _aBlood Coagulation Tests
650 0 4 _aDrug Stability
650 0 4 _aFactor Xa Inhibitors
650 0 4 _aFibrinolytic Agents
_xchemical synthesis
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aProtease Inhibitors
_xchemical synthesis
650 0 4 _aProtein Binding
650 0 4 _aStructure-Activity Relationship
700 1 _aMatter, Hans
700 1 _aKlingler, Otmar
700 1 _aAl-Obeidi, Fahad
700 1 _aSchreuder, Herman
700 1 _aZoller, Gerhard
700 1 _aCzech, Jörg
700 1 _aLorenz, Martin
700 1 _aDudda, Angela
700 1 _aPeyman, Anusch
700 1 _aNestler, Hans Peter
700 1 _aUrmann, Matthias
700 1 _aBauer, Armin
700 1 _aLaux, Volker
700 1 _aWehner, Volkmar
700 1 _aWill, David W
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 14
_gno. 11
_gp. 2801-5
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2004.03.059
_zAvailable from publisher's website
999 _c14836066
_d14836066